GaryVonBurtonMD

Oncology • Shreveport, LA

Professor, Medicine, Louisiana State University School of Medicine, Shreveport

Join to view full profile

Are you Dr. Burton?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

Connect with colleagues in the same hospital or clinic
You already have 70 invites waiting!
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

Claim this profile

Not you? Find your profile

Office
1501 Kings Hwy
Department of Medicine
Shreveport, LA 71103
Phone+1 318-675-4881

Fax+1 318-675-5069
Is this information wrong?

Summary

Dr. Gary Burton, MD is an oncologist in Shreveport, Louisiana. He is currently licensed to practice medicine in Louisiana and North Carolina. He is affiliated with Ochsner LSU Health Shreveport - Academic Medical Center, Ochsner LSU Health Shreveport, and Willis-Knighton Medical Center.

Education & Training

Duke University HospitalFellowship, Hematology and Medical Oncology, 1981 - 1983
Duke University HospitalResidency, Otolaryngology - Head and Neck Surgery, 1979 - 1981
Duke University HospitalInternship, Internal Medicine, 1978 - 1979
University of Utah School of MedicineClass of 1978

Certifications & Licensure

LA State Medical License 1987 - 2024
NC State Medical License 1978 - 2002
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

America's Top Doctors Castle Connolly, 2010-2014
America's Top Doctors for Cancer Castle Connolly, 2009-2013

Clinical Trials

Aspirin in Reducing Events in the Elderly Start of enrollment: 2010 Jan 01
Active, not recruiting
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15
Active, not recruiting
Phase 3
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer Start of enrollment: 2011 Jan 06
Active, not recruiting
Phase 3
S0820, Adenoma and Second Primary Prevention Trial Start of enrollment: 2013 Aug 23
Active, not recruiting
Phase 3
S1013: Validation of Cancer Questionnaire for Skin Toxicities in Patients With Colorectal Cancer or Lung Cancer Receiving Cetuximab, Panitumumab, or Erlotinib Hydrochloride Start of enrollment: 2011 Nov 15
Completed
S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer Start of enrollment: 2012 Feb 01
Completed
Phase 2
S1202: Duloxetine Hydrochloride for Muscle/Joint Pain in Early-Stage Breast Cancer Receiving Hormone Therapy Start of enrollment: 2013 May 15
Completed
Phase 3
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi Start of enrollment: 2012 Oct 03
Terminated
Phase 3
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer Start of enrollment: 2013 Sep 12
Active, not recruiting
Phase 3
S1222 Trial (Everolimus, Anastrozole and Fulvestrant) in Post-Menopausal Stage IV Breast Cancer Start of enrollment: 2014 May 01
Terminated
Phase 3
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer Start of enrollment: 2015 Jul 26
Recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

2 citations
A prospective study to validate the functional assessment of cancer therapy (FACT) for epidermal growth factor receptor inhibitor (EGFRI)-induced dermatologic toxiciti...
Siu-Fun Wong, Joseph M. Unger, James L. Wade, Lynne I. Wagner, Mario E. Lacouture, Keisha C. Humphries, Anna Moseley, Kathryn B. Arnold, Mario R. Velasco, Justin D. Fl...> ;Journal of Patient-Reported Outcomes. 2020 Jul 8
53 citations
Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infection among Patients with Newly Diagnosed Cancer from Academic and Community Oncology Practices
Scott D. Ramsey, Joseph M. Unger, Laurence H. Baker, Richard F. Little, Rohit Loomba, Jessica P. Hwang, Rashmi Chugh, Monica A. Konerman, Kathryn B. Arnold, Alex R. Me...> ;JAMA Oncology. 2019 Apr 1
3 citations
Utility of routine pretreatment evaluation of left ventricular ejection fraction in breast cancer patients receiving anthracyclines.
Prakash Peddi, Samip Master, Ashish Dwary, Hari P Ravipati, Abhishek Patel, Avinash Pasam, Pavan Katikaneni, Runhua Shi, Gary V. Burton, Quyen D. Chu> ;The Breast Journal. 2019 Jan 1
54 citations
Randomized, Multicenter, Placebo-Controlled Clinical Trial of Duloxetine Versus Placebo for Aromatase Inhibitor–Associated Arthralgias in Early-Stage Breast Cancer: SW...
N. Lynn Henry, Joseph M. Unger, Anne F. Schott, Louis Fehrenbacher, Patrick J. Flynn, Debra M. Prow, Carl W. Sharer, Gary V. Burton, Charles S. Kuzma, Anna Moseley, Da...> ;Journal of Clinical Oncology. 2017 Nov 14
47 citations
Excellent response to chemotherapy post immunotherapy
Ashish Dwary, Samip Master, Abhishek Patel, Constance Cole, Richard Mansour, Glenn Mills, Nebu Koshy, Prakash Peddi, Gary V. Burton, Dalia Hammoud, Kavitha Beedupalli> ;Oncotarget. 2017 Aug 8
10 citations
Regression of a glioblastoma multiforme: spontaneous versus a potential antineoplastic effect of dexamethasone and levetiracetam.
Prakash Peddi, Nisha Elizabeth Ajit, Gary V. Burton, Hazem E El-Osta> ;BMJ Case Reports. 2016 Dec 23
8 citations
Effect of Postmastectomy Radiation on Survival of AJCC pN2/N3 Breast Cancer Patients
Zhenzhen Shi, Prakash Peddi, Gary V. Burton, Glenn Mills, Runhua Shi> ;Anticancer Research. 2016 Jan 1
2 citations
Private Payer's Status Improves Male Breast Cancer Survival
Runhua Shi, Hannah Taylor, Lihong Liu, Glenn Mills, Gary V. Burton> ;The Breast Journal. 2016 Jan 1
45 citations
Effects of payer status on breast cancer survival: a retrospective study
Runhua Shi, Hannah Taylor, Jerry McLarty, Lihong Liu, Glenn Mills, Gary V. Burton> ;BMC Cancer. 2015 Apr 1
70 citations
SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer
George Thomas Budd, William E. Barlow, Halle C. F. Moore, Timothy J. Hobday, James A. Stewart, Claudine Isaacs, Muhammad Salim, Jonathan K. Cho, Kristine Rinn, Kathy S...> ;Journal of Clinical Oncology. 2015 Jan 1
16 citations
Commercial Insurance Triples Chances of Breast Cancer Survival in a Public Hospital
Runhua Shi, Glenn Mills, Jerry McLarty, Gary Von Burton, Zhenzhen Shi, Jonathan Glass> ;The Breast Journal. 2013 Nov 1
41 citations
Does obesity have an effect on outcomes in triple-negative breast cancer?
Ronny Mowad, Quyen D. Chu, Benjamin D.L. Li, Gary V. Burton, Frederico L. Ampil, Roger H. Kim> ;The Journal of Surgical Research. 2013 Sep 1
2 citations
Morbid obesity does not disadvantage patients with in situ or early-stage carcinoma undergoing breast-conserving surgery.
Federico L. Ampil, Gloria Caldito, Benjamin Li, Srinivas Devarakonda, Gary V. Burton, Roger H. Kim, Quyen D. Chu> ;Anticancer Research. 2013 Sep 1
1 citations
Is Baseline Bone Imaging in High-Risk Breast Cancer Patients Justified?
Federico L. Ampil, B. Li, Gary V. Burton, Roger H. Kim, Roxana Baluna, Quyen D. Chu> ;The Breast Journal. 2012 Nov 1
8 citations
Carcinoma of the axillary tail of Spence: a case series.
Federico L. Ampil, Gloria Caldito, Benjamin Henderson, Benjamin D. Li, Roger H. Kim, Gary V. Burton, Quyen D. Chu> ;Anticancer Research. 2012 Sep 1
3 citations
Should a Routine Metastatic Workup Be Performed for all Patients with Pathologic N2/N3 Breast Cancer?
Quyen D. Chu, Amanda Henderson, Roger H. Kim, J. Karen Miller, Gary V. Burton, F.L. Ampil, Benjamin D.L. Li> ;Journal of the American College of Surgeons. 2012 Apr 1
1 citations
Superwarfarin intoxication: two case reports and review of pathophysiology and patient management.
Kaylin S. Watson, Glenn Mills, Gary V. Burton> ;The Journal of the Louisiana State Medical Society. 2012 Mar 1
18 citations
Osteonecrosis of the Jaw in Patients with Metastatic Breast Cancer: Ethnic and Socio‐Economic Aspects
Dolly Quispe, Runhua Shi, Gary V. Burton> ;The Breast Journal. 2011 Sep 1
First analysis of SWOG S0221: A phase III trial comparing chemotherapy schedules in high-risk early breast cancer.
Budd GT, Barlow WE, Moore HCF, Hobday TJ, Stewart JA, Isaacs C, Salim M, Cho JK, Rinn K, Albain KS, Chew HK, Burton GV, Moore TD, Srkalovic G, McGregor BA, Flaherty LE...> ;J. Clin. Oncol.. 2011-05-20
4 citations
Trimodal therapy for inflammatory breast cancer: a surgeon's perspective.
Benjamin D. Li, Mark A. Sicard, F.L. Ampil, Fleurette Abreo, David L. Lilien, Quyen D. Chu, Gary V. Burton> ;Oncology. 2010 Nov 3
5 citations
Carcinomatous meningitis secondary to transitional cell bladder cancer.
Casey D. Bowen, Gary V. Burton, Rebecca C. Bargen, Songlin Zhang, Eduardo Gonzalez Toledo, Richard M. Zweig, Chaitanya Pant> ;Southern Medical Journal. 2010 Aug 1
23 citations
Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer?
Catherine C. Parker, F.L. Ampil, Gary V. Burton, Benjamin D.L. Li, Quyen D. Chu> ;Surgery. 2010 Aug 1
54 citations
Cisplatin-gemcitabine therapy in metastatic breast cancer: Improved outcome in triple negative breast cancer patients compared to non-triple negative patients.
Nebu Koshy, Dolly Quispe, Runhua Shi, Richard Mansour, Gary V. Burton> ;Breast. 2010 Jun 1
9 citations
Impact of Race and Ethnicity on Outcomes for Estrogen Receptor-Negative Breast Cancers: Experience of an Academic Center with a Charity Hospital
Quyen D. Chu, Gary V. Burton, Jonathan D. Glass, Mark H. Smith, Benjamin D.L. Li> ;Journal of the American College of Surgeons. 2010 May 1
10 citations
Predictive value of eIF4E reduction after neoadjuvant therapy in breast cancer.
David J. Hiller, Quyen D. Chu, Carol Meschonat, Lori Panu, Gary V. Burton, Benjamin D.L. Li> ;The Journal of Surgical Research. 2009 Oct 1
Join now to see all

Press Mentions

Hepatitis Goes Undiagnosed in Cancer PatientsJanuary 17th, 2019

Professional Memberships

American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Ochsner LSU Health Shreveport - Monroe Medical CenterMonroe, Louisiana
Ochsner LSU Health Shreveport - Academic Medical CenterShreveport, Louisiana
Overton Brooks Veterans' Administration Medical CenterShreveport, Louisiana
De Soto Regional Health SystemMansfield, Louisiana
Willis-Knighton Medical CenterShreveport, Louisiana
Ochsner LSU Health ShreveportShreveport, Louisiana